Articles by Disease (Hematological Malignancies)

Clinical and Genetic Features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) Syndrome

Journal: Current Molecular Medicine
Volume: 11
Page: 317-325
Author(s): L. Dotta, L. Tassone and R. Badolato

Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets

Journal: Current Drug Targets
Volume: 12
Page: 1056-1081
Author(s): Karolina Blajecka, Anna Borgstrom and Alexandre Arcaro

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2686-2714
Author(s): S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke and P. Workman

mTOR Inhibitors: Facing New Challenges Ahead

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2743-2762
Author(s): I. Mavrommati and T. Maffucci

Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2885-2892
Author(s): I. Filippi, A. Naldini and F. Carraro

BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile

Journal: Current Medicinal Chemistry
Volume: 18
Page: 2943-2959
Author(s): F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare and A. Carotti

Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic

Journal: Current Pharmaceutical Design
Volume: 17
Page: 1970-1978
Author(s): Andrew P. Mazar, Richard W. Ahn and Thomas V. O'Halloran